NYSE: RMDResmed Inc Stock Ownership - Who owns Resmed?
Insider buying vs selling
Have Resmed Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael J. Farrell | Chief Executive Officer | 2025-06-09 | 8,009 | $251.21 | $2.01MSell |
| Michael J. Farrell | Chief Executive Officer | 2025-06-09 | 8,009 | $101.64 | $814.03kBuy |
| Peter C. Farrell | Director | 2025-06-04 | 2,000 | $247.32 | $494.64kSell |
| Michael J. Rider | Global General Counsel | 2025-06-02 | 41 | $243.78 | $9.99kSell |
| Brett Sandercock | Chief Financial Officer | 2025-06-02 | 1,000 | $243.78 | $243.78kSell |
| Michael J. Rider | Global General Counsel | 2025-06-02 | 267 | $244.79 | $65.36kSell |
| Brett Sandercock | Chief Financial Officer | 2025-05-22 | 3,644 | $244.59 | $891.29kSell |
| Witte Jan De | Director | 2025-05-20 | 2,000 | $243.47 | $486.94kSell |
| Michael J. Farrell | Chief Executive Officer | 2025-05-07 | 8,009 | $243.23 | $1.95MSell |
| Peter C. Farrell | Director | 2025-05-07 | 2,000 | $242.25 | $484.50kSell |
RMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RMD insiders and whales buy or sell their stock.
RMD Shareholders
What type of owners hold Resmed Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 12.61% | 18,493,702 | $4.61B | Institution |
| Blackrock Inc | 8.66% | 12,692,014 | $3.16B | Institution |
| State Street Corp | 4.47% | 6,551,404 | $1.63B | Institution |
| Bank Of New York Mellon Corp | 3.55% | 5,204,217 | $1.30B | Institution |
| Morgan Stanley | 2.82% | 4,139,611 | $1.03B | Institution |
| Geode Capital Management LLC | 2.81% | 4,116,428 | $1.03B | Institution |
| Invesco Ltd | 1.56% | 2,294,031 | $571.99M | Institution |
| Northern Trust Corp | 1.19% | 1,744,541 | $434.98M | Institution |
| Christopher G. Roberts | 1.16% | 1,700,337 | $423.96M | Insider |
| Michael A. 1. Quinn | 0.87% | 1,277,650 | $318.57M | Insider |
RMD vs Medical Stocks
Resmed Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.